Industry Committee on Oct. 26th, 2010

Evidence of meeting #40 for Industry, Science and Technology in the 40th Parliament, 3rd Session. (The original version is on Parliament’s site, as are the minutes.) The winning word was drugs.

A recording is available from Parliament.

On the agenda

Bill C-393, An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act

MPs speaking

Also speaking

Richard Dearden Partner, Gowlings, As an Individual

Rachel Kiddell-Monroe Chair, Universities Allied for Essential Medicines

Amir Attaran Canada Research Chair, Law, Population Health, and Global Development Policy, University of Ottawa, As an Individual

Joshua Kimani Canadian Medical Institute in Kenya, As an Individual

Frederick Abbott Edward Ball Eminent Scholar, Professor of International Law, Florida State University College of Law, As an Individual

Linda Watson Member, National Advocacy Committee of the Grandmothers to Grandmothers Campaign

Elizabeth Rennie Member, National Advocacy Committee of the Grandmothers to Grandmothers Campaign

Angus Livingstone Managing Director, University-Industry Liaison Office, University of British Columbia, As an Individual

Emilou MacLean Director, United States of America, Campaign for Access to Essential Medicines, Doctors Without Borders

Grant Perry Vice-President, Public Affairs/Reimbursement, GlaxoSmithKline Canada

Russell Williams President, Canada's Research-Based Pharmaceutical Companies (Rx & D)

Laurence Dotto Director, Government and External Affairs, Canada's Research-Based Pharmaceutical Companies (Rx & D)

Frank Plummer Scientific Director General, National Microbiology Laboratory, Public Health Agency of Canada

Jim Keon President, Canadian Generic Pharmaceutical Association

David Schwartz Chair, Biotechnology Patents Committee, Intellectual Property Institute of Canada

Antony Taubman Director, Intellectual Property Division, World Trade Organization (WTO)

Paula Akugizibwe Advocacy Coordinator, AIDS and Rights Alliance for Southern Africa

Andrew Jenner Director, Intellectual Property and Trade, International Federation of Pharmaceutical Manufacturers and Associations

1 p.m.

Conservative

The Chair Conservative David Sweet

That will have to be the final word on this today.

Members, please remember that at our next meeting on Thursday there will be clause-by-clause consideration. We will have officials here. Please, if possible, make sure that any amendments you're going to propose will be in by tomorrow at noon so we will have time to correlate them. As well, there is a steering committee meeting at 10 a.m. on Thursday.

That concludes our meeting. The meeting is adjourned.